199 related articles for article (PubMed ID: 17430149)
1. AMPA receptors in the therapeutic management of depression.
Bleakman D; Alt A; Witkin JM
CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):117-26. PubMed ID: 17430149
[TBL] [Abstract][Full Text] [Related]
2. A role for AMPA receptors in mood disorders.
Alt A; Nisenbaum ES; Bleakman D; Witkin JM
Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
[TBL] [Abstract][Full Text] [Related]
3. AMPA receptor potentiators for the treatment of CNS disorders.
O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor potentiators as novel antidepressants.
Alt A; Witkin JM; Bleakman D
Curr Pharm Des; 2005; 11(12):1511-27. PubMed ID: 15892659
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antidepressant potency by a potentiator of AMPA receptors.
Li X; Witkin JM; Need AB; Skolnick P
Cell Mol Neurobiol; 2003 Jun; 23(3):419-30. PubMed ID: 12825836
[TBL] [Abstract][Full Text] [Related]
6. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
7. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
Nguyen L; Matsumoto RR
Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
[TBL] [Abstract][Full Text] [Related]
8. Glutamate and depression: clinical and preclinical studies.
Paul IA; Skolnick P
Ann N Y Acad Sci; 2003 Nov; 1003():250-72. PubMed ID: 14684451
[TBL] [Abstract][Full Text] [Related]
9. 3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.
Li B; Hou Y; Zhu M; Bao H; Nie J; Zhang GY; Shan L; Yao Y; Du K; Yang H; Li M; Zheng B; Xu X; Xiao C; Du J
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26443809
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62.
Lv D; Chen Y; Shen M; Liu X; Zhang Y; Xu J; Wang C
Neuropharmacology; 2018 Dec; 143():317-326. PubMed ID: 30291938
[TBL] [Abstract][Full Text] [Related]
11. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
12. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
eNeuro; 2017; 4(1):. PubMed ID: 28275719
[TBL] [Abstract][Full Text] [Related]
13. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
[TBL] [Abstract][Full Text] [Related]
14. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
Yu H; Li M; Zhou D; Lv D; Liao Q; Lou Z; Shen M; Wang Z; Li M; Xiao X; Zhang Y; Wang C
Neuropharmacology; 2018 Mar; 131():209-222. PubMed ID: 29274366
[TBL] [Abstract][Full Text] [Related]
15. BDNF release is required for the behavioral actions of ketamine.
Lepack AE; Fuchikami M; Dwyer JM; Banasr M; Duman RS
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539510
[TBL] [Abstract][Full Text] [Related]
16. AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test.
Linck VM; Costa-Campos L; Pilz LK; Garcia CR; Elisabetsky E
Behav Pharmacol; 2012 Apr; 23(2):171-7. PubMed ID: 22327021
[TBL] [Abstract][Full Text] [Related]
17. Glutamate modulators as novel interventions for mood disorders.
Mathew SJ; Keegan K; Smith L
Braz J Psychiatry; 2005 Sep; 27(3):243-8. PubMed ID: 16224615
[TBL] [Abstract][Full Text] [Related]
18. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants.
Crozatier C; Farley S; Mansuy IM; Dumas S; Giros B; Tzavara ET
Neuroscience; 2007 Feb; 144(4):1470-6. PubMed ID: 17207580
[TBL] [Abstract][Full Text] [Related]
20. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?
Freudenberg F; Celikel T; Reif A
Neurosci Biobehav Rev; 2015 May; 52():193-206. PubMed ID: 25783220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
